For example, in CD14+ monocytes freshly isolated from peripheral blood of SS-patients, several miRNAs are differentially upregulated, preferentially targeting TGF-β signaling pathway components, such as SMAD4, whose expression is repressed in a subpopulation of SS-patients. This evidence concerns the gene CD14 and synovial sarcoma.